DashboardWarning LettersWarning Letter Details

Peak Performance Peptides Warning Letter Details

Warning Letter
View Letter

Peak Performance Peptides

3935 E Rough Rider Rd Unit 1016 Phoenix , AZ 85050 United States, (b)(6), (b)(7)(C)
Issue DateAugust 24, 2026
FEI NumberN/A
Violations1
CountryUnited States
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open

Subject

Unapproved New Drugs/Misbranded

Peak Performance Peptides FDA Warning Letter, August 24, 2026